EP Patent

EP4606784A2 — Co-crystals, salts and solid forms of tenofovir alafenamide

Assigned to Gilead Sciences Inc · Expires 2025-08-27 · 1y expired

What this patent protects

The present invention relates to co-crystals, salts and crystalline forms of tenofovir alafenamide and methods for preparation, use and isolation of such compounds

USPTO Abstract

The present invention relates to co-crystals, salts and crystalline forms of tenofovir alafenamide and methods for preparation, use and isolation of such compounds

Drugs covered by this patent

Patent Metadata

Patent number
EP4606784A2
Jurisdiction
EP
Classification
—
Expires
2025-08-27
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.